said over-diagnosis of prostate cancer is what makes screening appear life-saving when it actually isn't. Most of these men may never have a tumor progress to become deadly, but since they were screened and treated, they think screening saves...
When the United States Preventive Services Task Force (USPSTF) recommended against routine PSA screening for early detection of prostate cancer in May 2012, it caused a sea change in practice patterns among primary care physicians. The impact of the recommendations had “a significant chilling effect...
Prostate cancer screening practices and diagnoses in patients age 50 and older, Southeastern Michigan, pre/post 2012. Prev. Med. 82, 73–76 (2016). Article PubMed Google Scholar Sammon, J. et al. Age dependent variation in the effect of physician recommendations to undergo prostate specific...
PSA Screening Recommendations Periodic prostate cancer screening is recommended for some males. With that said, the public health recommendations vary due in part to uncertainties as to whether the benefits of screening outweigh the risks of overdiagnosis and overtreatment. Because of this, three leading...
More attention to prognosis is needed when making screening PSA recommendations to elderly men.doi:10.1001/jama.296.19.2336A.S. KibelJama the Journal of the American Medical Association
10 In response, we created a clinical computerized decision support (CCDS) tool to remind providers of current recommendations against PSA-based prostate cancer screening for men in this age group. The tool, a “reminder order check,” or “pop-up” alert, was a new decision support option ...
The USPSTF recommends against prostate cancer screening for men over 70. Many other professional healthcare organizations, associations, and societies have similar recommendations for prostate cancer screening. Screening is also recommended for: Younger men with a family history of prostate cancer or relat...
Several studies subsequently showed a rise in metastaticprostate cancer diagnosis, but the role of PSA screening reductions in those findings was unclear. In 2018, the USPSTF updated its recommendations, stating that men aged 55-69 years should make "an individual decision about whether to be scree...
= 162 243)1 and in the United States (the Prostate, Lung, Colorectal, and Ovarian Cancer Screening [PLCO] trial, N = 76 693)2 has not resolved the controversies surrounding prostate-specific antigen (PSA)–based prostate cancer screening, resulting in different recommendations ...
While the USPSTF acknowledges that family history and African American race are two of the most significant risk factors for developing prostate cancer, the panel maintains that there is insufficient evidence to issue individualized screening recommendations in any age group based on those factor...